ArticleThe journal of headache and pain2026
Functional connectome gradient alterations in herpes zoster and postherpetic neuralgia: associations with gene expression profiles.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundHerpes zoster (HZ) and postherpetic neuralgia (PHN) are severe neuropathic pain disorders. However, the alterations in their macroscopic brain-functional architecture and their potential molecular correlations remain poorly understood. This study was aimed at characterizing the altered functional connectivity patterns in the brains of patients with HZ and PHN using a connectome gradient analysis and further explore the potential associations with gene expression patterns through a spatial transcriptomics correlation analysis.
methodsIn this study, 95 patients with HZ, 89 patients with PHN, and 84 matched healthy controls were characterized through a connectome gradient analysis. Additionally, transcriptomic neuroimaging association analyses were conducted using gene expression data derived from the Allen Human Brain Atlas and case‒control gradient differences to identify the genes that were associated with gradient variations. Finally, an enrichment analysis was performed on the identified significant genes to explore the biological pathways and cell types in which they may be involved.
resultsCompared with the healthy controls, HZ exhibited in the whole-brain gradients shrinkage. HZ showed abnormal subgradient values within the sensorimotor and dorsal attention networks, with exploratory associations to anxiety scores. PHN was characterized by reduced main gradient values in the frontoparietal control network, with exploratory associations to depression scores. The transcriptomic neuroimaging association analysis revealed that the gradient abnormalities in HZ were spatially correlated with gene expression patterns involving synaptic functions and ion channels, whereas the abnormalities in PHN were spatially correlated with the genes involved in postsynaptic signaling and the regulation of endogenous opioids. Cellular analysis indicated that HZ-associated genes were predominantly enriched in inhibitory and excitatory neurons and astrocytes, whereas PHN-associated genes were enriched in both neuron types.
conclusionsThis study is the first to identify functional connectome and associated gene expression profiles in HZ and PHN through a cross-scale perspective that encompasses both functional connectome gradients and gene expressions. Our findings provide novel insights into the spatial transcriptomic correlates of functional alterations in the brain under these conditions and provide a foundation for conducting hypothesis-driven research on potential biomarkers and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.